Article may be outdated

This article is 69 days old. Some details may have changed since publication.

The Guardian·3 min read·medium

London startup to trial drug to prevent cancer therapy side-effect ‘cytokine storm’

London startup to trial drug to prevent cancer therapy side-effect ‘cytokine storm’
AI Summary

This article covers: London startup to trial drug to prevent cancer therapy side-effect ‘cytokine storm’

Why it matters

This story may be significant to current events.

Dive DeeperCreate a free account to unlock

The drug is about to be tested on 30 people at six hospitals in Britain. Photograph: Thomas Coex/AFP/Getty View image in fullscreen The drug is about to be tested on 30 people at six hospitals in Britain. Photograph: Thomas Coex/AFP/Getty Pharmaceuticals industry London startup to trial drug to prevent cancer therapy side-effect ‘cytokine storm’ Poolbeg Pharma to test the treatment in NHS hospitals and says it is also developing a GLP-1 weight loss pill

Continue reading on Headlinne

Create a free account to read the full article.

Read full article →
world
Political Bias
Center~
LeftLean LCenterLean RRight
Confidence: 40%

Analysis not available — rate limit reached.

Get smarter about the news

Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.

Create free account

Already have an account? Sign in